ES2107375B1 - LIQUID PHARMACEUTICAL FORMULATIONS OF EBASTIN BY ORAL WAY. - Google Patents
LIQUID PHARMACEUTICAL FORMULATIONS OF EBASTIN BY ORAL WAY.Info
- Publication number
- ES2107375B1 ES2107375B1 ES9501556A ES9501556A ES2107375B1 ES 2107375 B1 ES2107375 B1 ES 2107375B1 ES 9501556 A ES9501556 A ES 9501556A ES 9501556 A ES9501556 A ES 9501556A ES 2107375 B1 ES2107375 B1 ES 2107375B1
- Authority
- ES
- Spain
- Prior art keywords
- liquid pharmaceutical
- pharmaceutical formulations
- ebastin
- oral way
- formulations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
FORMULACIONES FARMACEUTICAS LIQUIDAS DE EBASTINA POR VIA ORAL. FORMULACIONES FARMACEUTICAS LIQUIDAS DE 4 -DIFENILMETOXI -1- [3- (4-TERBUTILBENZOIL) PROPIL] PIPERIDINA, CUYA DENOMINACION COMAN ES EBASTINA, QUE CONTIENEN ACIDOS CARBOXILICOS HIDROXILADOS, TENSIOACTIVOS NO IONICOS Y POLIOLES DE CADENA MEDIA EN UNA PROPORCION COMPRENDIDA ENTRE 1:1:3:25 Y 3:10:25:500 RESPECTIVAMENTE, JUNTO CON EXCIPIENTES O DILUYENTES FARMACEUTICAMENTE ACEPTABLES. ESTAS FORMULACIONES SE UTILIZAN PARA EL TRATAMIENTO DE PROCESOS ALERGICOS COMO RINITIS, URTICARIA, DERMATITIS O CONJUNTIVITIS.LIQUID PHARMACEUTICAL FORMULATIONS OF EBASTIN BY ORAL WAY. LIQUID PHARMACEUTICAL FORMULATIONS OF 4-DIPHENYLMETOXY -1- [3- (4-TERBUTILBENZOIL) PROPIL] PIPERIDINE, WHICH IS A DENOMINATION WHICH IS COMBINED BY EBASTINE, WHICH CONTAINS 1-CARBYLIC ACIDES, HYDROXYLATED TENSIOES : 3: 25 AND 3: 10: 25: 500 RESPECTIVELY, TOGETHER WITH PHARMACEUTICALLY ACCEPTABLE EXCIPIENTS OR THINNERS. THESE FORMULATIONS ARE USED FOR THE TREATMENT OF ALLERGIC PROCESSES LIKE RHINITIS, URTICARIA, DERMATITIS OR CONJUNTIVITIS.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9501556A ES2107375B1 (en) | 1995-08-01 | 1995-08-01 | LIQUID PHARMACEUTICAL FORMULATIONS OF EBASTIN BY ORAL WAY. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9501556A ES2107375B1 (en) | 1995-08-01 | 1995-08-01 | LIQUID PHARMACEUTICAL FORMULATIONS OF EBASTIN BY ORAL WAY. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2107375A1 ES2107375A1 (en) | 1997-11-16 |
ES2107375B1 true ES2107375B1 (en) | 1998-07-01 |
Family
ID=8291245
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES9501556A Expired - Fee Related ES2107375B1 (en) | 1995-08-01 | 1995-08-01 | LIQUID PHARMACEUTICAL FORMULATIONS OF EBASTIN BY ORAL WAY. |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2107375B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013081562A1 (en) | 2011-10-13 | 2013-06-06 | Mahmut Bilgic | Oral formulations comprising ebastine |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2568473B1 (en) * | 1984-08-03 | 1987-05-15 | Vaillant Defresne Laboratoire | NEW COMPOSITION BASED ON QUININE FORMIATE |
FR2624736B1 (en) * | 1987-12-16 | 1991-03-22 | Dietlin Francois | NEW WATER-DISPERSIBLE PHARMACEUTICAL COMPOSITIONS BASED ON ORNIDAZOLE |
ZA90341B (en) * | 1989-01-23 | 1990-10-31 | Merrell Dow Pharma | Liquid pharmaceutical composition for piperidinoalkanol derivatives |
FR2673842B1 (en) * | 1991-03-13 | 1993-12-24 | Rhone Poulenc Rorer Sa | NOVEL LIQUID COMPOSITIONS BASED ON 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES. |
US5574045A (en) * | 1995-06-06 | 1996-11-12 | Hoechst Marion Roussel, Inc. | Oral pharmaceutical composition of piperidinoalkanol compounds in solution form |
-
1995
- 1995-08-01 ES ES9501556A patent/ES2107375B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2107375A1 (en) | 1997-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO971206D0 (en) | Prolonged-frigjöringsformulering | |
AR026610A1 (en) | A PIRROLIDINACETAMIDE DERIVATIVE ONLY OR IN COMBINATION FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | |
CR9842A (en) | CELECOXIB COMPOSITIONS | |
NO951613L (en) | Non-peptidyl tachykinin receptor antagonists | |
AR008853A1 (en) | NEW PHARMACEUTICALLY ACTIVE COMPOUNDS, THEIR USE IN THE MANUFACTURE OF MEDICINES, TREATMENT METHOD, PHARMACEUTICAL COMPOSITION, INTERMEDIATE COMPOUNDS AND PROCESS FOR THE MANUFACTURE OF SUCH COMPOUNDS | |
MA26901A1 (en) | NEW PHARMACEUTICAL COMPOSITION | |
DE59509751D1 (en) | AGING EFFECTS AGAINST SKIN AGING OR ACTIVE SUBSTANCE COMBINATIONS AND PREPARATIONS | |
AR018197A1 (en) | PIPERIDINE COMPOUNDS, A PROCEDURE FOR THE PREPARATION, A COMPOSITION AND USE OF THE SAME FOR THE PREPARATION OF A MEDICINAL PRODUCT | |
NO20051966L (en) | New pyrimidinamide derivatives and their use | |
BR0215184A (en) | orally active taxane derivative pharmaceutical compositions having increased bioavailability | |
GEP20022636B (en) | 4-[5-Methyl-3-Phenylisoxazol-4-Yl] Benzenesulfonamide, Its Crystal Structure B, Pharmaceutical Composition Containing The Same, Methods For Treatment Or Prophylaxis Of Disorders Caused By Cyclooxygen-2 | |
NO961687D0 (en) | New (R) -5-carbamoyl-8-fluoro-3-N, N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans | |
AR043188A1 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF DISEASES AND DISORDERS ASSOCIATED WITH ELEVATED LEVELS OF PROINFLAMATORY CYTOKINS | |
GT199800101A (en) | SOLID PHARMACEUTICAL COMPOSITION CONTAINING A DERIVATIVE OF BENZOFURANE. | |
ES2192234T3 (en) | PARENTERAL PHARMACEUTICAL COMPOSITIONS CONTAINING SALTS OF 2-ARILPROPIONIC ACIDS. | |
BR0013935A (en) | Optically active isomers of ketotifen and therapeutically active metabolites thereof | |
SV2002000235A (en) | PHARMACEUTICAL COMPOSITIONS THAT INCLUDE VALDECOXIB | |
DE59608698D1 (en) | Pharmaceutical preparation for the treatment of acute rhinitis, containing sympthomimeticum and pantothenol and / or pantothenic acid | |
GT199700037A (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RHINITIS | |
TR200400228T4 (en) | Substances used in the treatment of psoriasis | |
CO5190674A1 (en) | TREATMENT OF NEUROTIC DISORDERS NEUROTIC DISORDERS | |
RS50298B (en) | Directly compressibile matrix for controlled release of single daily doses of clarithromycin | |
DK1274685T3 (en) | A pyridine-N-oxide derivative and process for its conversion into pharmaceutically effective compounds | |
NO20000519L (en) | 2-acylaminopropanamines as tachykinin receptor antagonists | |
ATE87468T1 (en) | ANTACIDATE TABLETS. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 19971116 Kind code of ref document: A1 Effective date: 19971116 |
|
PC2A | Transfer of patent | ||
FD2A | Announcement of lapse in spain |
Effective date: 20180806 |